Terms: = Pancreatic cancer AND CEACAM5, CEA AND Clinical Outcome
6 results:
1. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer.
Hu L; Xu H; Wang X; Wu B; Chen F; Chen W; Gao Y; Zhong Z
Bioengineered; 2021 Dec; 12(1):2763-2778. PubMed ID: 34125004
[TBL] [Abstract] [Full Text] [Related]
2. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and outcomes after the Resection of Colorectal Liver Metastases.
Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma.
Distler M; Rückert F; Hunger M; Kersting S; Pilarsky C; Saeger HD; Grützmann R
BMC Surg; 2013 Apr; 13():12. PubMed ID: 23607915
[TBL] [Abstract] [Full Text] [Related]
4. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
[TBL] [Abstract] [Full Text] [Related]
5. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis.
Ohike N; Morohoshi T
Endocr Pathol; 2005; 16(1):33-40. PubMed ID: 16000844
[TBL] [Abstract] [Full Text] [Related]
6. [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].
Tendo M; Nakata B; Nishino H; Inoue M; Kosaka K; Amano R; Yamada N; Hirakawa K
Gan To Kagaku Ryoho; 2005 Jun; 32(6):795-8. PubMed ID: 15984518
[TBL] [Abstract] [Full Text] [Related]
